Midmark launches new division with innovation in mind, all the time

Founded in 1915 in Versailles, Ohio, 40 miles northwest of Dayton, Midmark Corporation has grown into a global leader and solutions provider in the healthcare industry, including medical, dental, and veterinary markets.

The privately-held company enjoys a significant leadership position in the physician’s office market. It estimates that its award-winning examination and diagnostic operatory products are utilized by more than 500,000 physicians thoughout the U.S. Midmark employs more than 1,500 teammates in 13 facilities located around the globe.

But when you speak with Midmark Medical Director Tom Schwieterman, MD, it’s obvious the company is not satisfied with success.

In what he calls “the fruition of an 8-year process of promoting innovation at Midmark,” the company launched Midmark Connect in late 2010 and established an office in West Chester, Ohio, last November. With a staff of five, including Dr. Schwieterman, the new division is highly focused on building upon the innovation already occurring at Midmark, while also pursuing new services and technology opportunities. An “open innovation” philosophy leads Midmark Connect’s efforts.

“We want to leverage Midmark’s expertise, market share, and access to the exam space to commercialize technologies originating inside and outside Midmark,” Schwieterman said. Specifically, they are seeking partners in diagnostic sensors, cloud-based disease management applications, and ideas that reduce readmissions, enable efficiencies, and improve outcomes.

An example of the Midmark Connect approach is last year’s launch of the SleepView Monitor and SleepView Portal, developed by Cleveland Medical Devices and licensed to Midmark.

Between Dr. Schwieterman, V.P. Jeff Wells, and Director of Business Development David Claire, at least one Midmark Connect exec makes the 90-minute trip north to Midmark headquarters each week. And corporate leadership periodically visits the new division’s open, modern digs for a different perspective.

After considering locations around the world for Midmark Connect, the Cincinnati area ultimately was chosen for its regional health care assets and talent base.

“We could have placed this office anywhere,” Schwieterman said. “But we all recognized that Ohio is an incredibly attractive place to start something like this, to tap into the wealth of health care knowledge and collaboration. That drove the investment.”

If you want to learn more about Midmark Connect or have an idea to pitch, Dr. Schwieterman wants to hear from you: 937-526-8722 or via LinkedIn.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

New study shows combining GanedenBC30 with prebiotics provides digestive health benefits | Ganeden, October 30, 2014

Charles River acquires ChanTest for up to $54M | GEN, October 30, 2014

Ashland Specialty Ingredients launches web-based film-coatings troubleshooting tool and new pharmaceutical excipients website | PR Web, October 30, 2014

IBM and Cleveland Clinic use Watson to advance genomic research for cancer care pilot | PR Newswire, October 29, 2014

Cleveland Clinic announces Top Ten medical innovations for 2015, mobile stroke unit and Dengue vaccine top list (video) | Cleveland.com, October 29, 2014

Ampersand Capital Partners exits ChanTest investment with sale to Charles River Laboratories | PR Newswire, October 29, 2014

Camargo Pharmaceutical Services meets growing client needs with appointment of industry leader Steven Castillo as Vice President Of Drug Development | BioSpace, October 29, 2014

Scientific breakthrough at Cincinnati Children’s Hospital Medical Center could help battle cancer, ulcers | Cincinnati Business Courier, October 29, 2014

Devicor Medical Products of Sharonville, Ohio acquired by Danaher Corporation’s Leica Biosystems | Cincinnati.com, October 28, 2014

GTCR announces sale of Devicor Medical Products to Danaher Corporation’s Leica Biosystems | Business Wire, October 28, 2014

Researchers at Cincinnati Children’s Hospital Medical Center studying how to create replacement organs for people who need transplants | Cincinnati Business Courier, October 28, 2014

Juventas Therapeutics strengthens management team with new senior vice president of finance and operations, Troy Ignelzi | PR Newswire, October 28, 2014

Enable Injections signs strategic development agreement with CSL Behring to market novel drug delivery device | Philadelphia Business Journal, October 28, 2014

Ohio’s 2014 Bioproduct World Conference names Magic Dirt of Little Rock, Arkansas the Bioproduct Innovation of the Year | Wisconsin State Farmer, October 28, 2014

Ohio Soybean Council Foundation offers $36,000 in scholarships, majors include biotechnology | Ohio Soybean Council Foundation, October 28, 2014

Danaher’s Leica Biosystems division agrees to buy Devicor Medical Products, a developer of breast biopsy products | MASS Device, October 28, 2014

University Hospitals selects GenomOncology’s GO Clinical Workbench to launch their first NGS-based cancer diagnostic test | PR Newswire, October 27, 2014

INC Research of Raleigh, NC and the former Kendle location in Cincinnati, OH, plans IPO of up to $156M | Triangle Business Journal, October 27, 2014

NASA Glenn Research Center’s new office building is an example of continued commitment to Brook Park | Cleveland.com, October 27, 2014

Innovators huddle before taking on the Cleveland Clinic’s Innovation Summit | Cleveland.com, October 27, 2014